(Q40383475)

20 September 2017

1 reference

title

Impact of prostate-specific antigen screening on the natural history of prostate cancer (English)

1 reference

20 September 2017

Rosen MA

1

1 reference

PubMed ID

7502411

20 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

20 September 2017

1 reference

20 September 2017

46

1 reference

20 September 2017

757-768

1 reference

20 September 2017

6

1 reference

20 September 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Watchful waiting for early stage prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prognostic significance of lymph nodal metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

High 10-year survival rate in patients with early, untreated prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

1 reference

7 January 2021

The nature of prostate cancer detected through prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Patient age as a prognostic factor in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The risk of dying of prostate cancer in patients with clinically localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Statistical and epidemiologic data on urologic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The Treatment of Stage C Prostatic Cancer with Special Reference to Combined Surgical and Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Management of Stage D1 Adenocarcinoma of the Prostate: The Johns Hopkins Experience 1974 to 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Adjuvant therapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The challenge of treating node-positive prostate cancer. An approach to resolving the questions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Result of treatment of patients with stage D1 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Pelvic lymph node dissection. Guide to patient management in clinically locally confined adenocarcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The pathological features and prognosis of prostate cancer detectable with current diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Impact of routine screening for adenocarcinoma of the prostate on stage distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Adenocarcinoma of the prostate: results of routine urological screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Assessment of screening for prostate cancer using the digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Progress and problems in screening for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Clinical observations on the doubling time of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Natural history of changes in prostate specific antigen in early stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Deferred treatment in clinically localised prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Natural history of localised prostatic cancer managed by conservative therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Expectant management of localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Screening for prostate cancer. A decision analytic view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

A Markov model of the natural history of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

A critique of the decision analysis for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Impact and cost-effectiveness of smoking interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

The histology and prognosis of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Gleason grading of prostate cancer: a predictor of survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radical Surgery for Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Radical prostatectomy for high grade disease: a reevaluation 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980339-2

7 January 2021

10.1016/S0090-4295(99)80339-2

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7502411